C. Andrew Bonham

Publications

• Pediatric combined heart-liver transplantation performed en bloc: A single-center experience
  Hill, A. L., Maeda, K., Bonham, C. A., & Concepcion, W. (2012). Pediatric combined heart-liver transplantation performed en bloc: A single-center experience. PEDIATRIC TRANSPLANTATION, 16(4), 392-397.
• Portal Venous Remodeling After Endovascular Reduction of Pediatric Autogenous Portosystemic Shunts
  Stewart, J. K., Kuo, W. T., Hovsepian, D. M., Hofmann, L. V., Bonham, C. A., & Sze, D. Y. (2011). Portal Venous Remodeling After Endovascular Reduction of Pediatric Autogenous Portosystemic Shunts. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 22(8), 1199-1205.
• Hepatic Epithelioid Hemangioendothelioma
  Liu, Y. I., Brown, S. S., Elihu, A., Bonham, C. A., Concepcion, W., & Kamaya, A. (2011). Hepatic Epithelioid Hemangioendothelioma. DIGESTIVE DISEASES AND SCIENCES, 56(2), 303-306.
• Hepatic Arteriovenous Malformations from Hereditary Hemorrhagic Telangiectasia: Treatment with Liver Transplantation Lee, M., Sze, D. Y., Bonham, C. A., & Daugherty, T. J. (2010). Hepatic Arteriovenous Malformations from Hereditary Hemorrhagic Telangiectasia: Treatment with Liver Transplantation. DIGESTIVE DISEASES AND SCIENCES, 55(11), 3059-3062.
  
• Fulminant Clostridium difficile Colitis in a Post-Liver Transplant Patient Lee, M., Shelton, A. A., Concepcion, W. L., Bonham, C. A., & Daugherty, T. J. (2010). Fulminant Clostridium difficile Colitis in a Post-Liver Transplant Patient. DIGESTIVE DISEASES AND SCIENCES, 55(9), 2459-2462.
  
• Management of Biliary Strictures Following Liver Transplantation Alexopoulos, S. P., Henningsen, J. A., Jeffrey, R. B., Bonham, C. A., Ahmed, A., & Gonzalez, S. A. (2009). Management of Biliary Strictures Following Liver Transplantation. DIGESTIVE DISEASES AND SCIENCES, 54(1), 25-27.
  
• Pediatric intestinal transplantation at Packard children's hospital/Stanford University medical center: Report of a four-year experience Castillo, R. O., Zarge, R., Cox, K., Strichartz, D., Berquist, W., & Esquivel, C. O. (2006). Pediatric intestinal transplantation at Packard children's hospital/Stanford University medical center: Report of a four-year experience. TRANSPLANTATION PROCEEDINGS, 38(6), 1716-1717.
  
• Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization Qiu, S. J., Lu, L., Qiao, C. P., Wang, L. F., Wang, Z., & Bonham, C. A. (2005). Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 131(7), 429-438.
  
• Mechanistic insights into impaired dendritic cell function by rapamycin: Inhibition of Jak2/Stat4 signaling pathway Chiang, P. H., Wang, L. F., Bonham, C. A., Liang, X. Y., Fung, J. J., & Qian, S. G. (2004). Mechanistic insights into impaired dendritic cell function by rapamycin: Inhibition of Jak2/Stat4 signaling pathway. JOURNAL OF IMMUNOLOGY, 172(3), 1355-1363.
  
• Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig Bonham, C. A., Peng, L. S., Liang, X. Y., Chen, Z. Y., Wang, L. F., & Lu, L. (2002). Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. JOURNAL OF IMMUNOLOGY, 169(6), 3382-3391.
  
• The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients Jain, A. Kb., Venkataramanan, R., Shapiro, R., Scantlebury, V. P., Potdar, S., & Fung, J. J. (2002). The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. LIVER TRANSPLANTATION, 8(9), 841-845.
  
• Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritc cell function Chiang, P. H., Wang, L., Liang, Y., Liang, X., Qian, S., & Lu, L. (2002). Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritc cell function. TRANSPLANTATION PROCEEDINGS, 34(5), 1394-1395.
  
• Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection Beckebaum, S., Cicinnati, V. R., Dworacki, G., Muller-Berghaus, J., Stolz, D., & Bonham, C. A. (2002). Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. CLINICAL IMMUNOLOGY, 104(2), 138-150.
  
• Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients Jain, A. Kb., Venkataramanan, R., Shapiro, R., Scantlebury, V. P., Potdar, S., & Fung, J. J. (2002). Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients. TRANSPLANTATION PROCEEDINGS, 34(5), 1540-1541.
  
• Liver-derived DEC205(+)B220(+)CD19(-) dendritic cells regulate T cell responses Lu, L. N., Bonham, C. A., Liang, X. Y., Chen, Z. Y., Li, W., & Qian, S. G. (2001). Liver-derived DEC205(+)B220(+)CD19(-) dendritic cells regulate T cell responses. JOURNAL OF IMMUNOLOGY, 166(12), 7042-7052.
  
• Hepatocyte-induced apoptosis of activated T cells, a mechanism of liver transplant tolerance, is related to the expression of ICAM-1 and hepatic lectin Qian, S., Wang, Z., Lee, Y., Chiang, Y., Bonham, C., & Lu, L. (2001). Hepatocyte-induced apoptosis of activated T cells, a mechanism of liver transplant tolerance, is related to the expression of ICAM-1 and hepatic lectin. TRANSPLANTATION PROCEEDINGS, 33(1-2), 226-226.
  
• Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up Kashyap, R., Jain, A., Reyes, J., Demetris, A. J., Elmagd, K. A., & Fung, J. J. (2001). Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1482-1483.
  
• Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up Kashyap, R., Jain, A., Reyes, J., Demetris, A. J., Elmagd, K. A., & Fung, J. J. (2001). Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1486-1487.
  
• A novel subset of dendritic cells propagated from the liver promotes differentiation of T regulatory cells and enhances allograft survival Lu, L., Liang, X., Li, W., Chen, Z., Nalesnick, M., & Qian, S. (2001). A novel subset of dendritic cells propagated from the liver promotes differentiation of T regulatory cells and enhances allograft survival. TRANSPLANTATION PROCEEDINGS, 33(1-2), 229-229.
  
• Long-term survival after liver transplantation in 4,000 consecutive patients at a single center Jain, A., Reyes, J., Kashyap, R., Dodson, F., Demetris, A. J., & Fung, J. J. (2000). Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. ANNALS OF SURGERY, 232(4), 490-498.
  
• Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation Dodson, S. F., de Vera, M. E., Bonham, C. A., Geller, D. A., Rakela, J., & Fung, J. J. (2000). Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. LIVER TRANSPLANTATION, 6(4), 434-439.
  
• Prolongation of cardiac allograft survival using dendritic cells treated with NF-kappa B decoy oligodeoxyribonucleotides Giannoukakis, N., Bonham, C. A., Qian, S. G., Zhou, Z. Y., Peng, L., & Lu, L. (2000). Prolongation of cardiac allograft survival using dendritic cells treated with NF-kappa B decoy oligodeoxyribonucleotides. MOLECULAR THERAPY, 1(5), 430-437.
  
• Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Marsh, J. W., Dvorchik, I., Bonham, C. A., & Iwatsuki, S. (2000). Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?. CANCER, 88(3), 538-543.
  
• Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors Dodson, S. F., Bonham, C. A., Geller, D. A., Cacciarelli, T. V., Rakela, J., & Fung, J. J. (1999). Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. TRANSPLANTATION, 68(7), 1058-1061.
  
• Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients Lu, L., Gambotto, A., Lee, W. C., Qian, S., Bonham, C. A., & Thomson, A. W. (1999). Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. GENE THERAPY, 6(4), 554-563.
  
• Potential use of marginal donors for pancreas transplantation Bonham, C. A., Kapur, S., Dodson, S. F., Dvorchik, I., & Corry, R. J. (1999). Potential use of marginal donors for pancreas transplantation. TRANSPLANTATION PROCEEDINGS, 31(1-2), 612-613.
  
• Excision and immediate revascularization for hepatic artery pseudoaneurysm following liver transplantation Bonham, C. A., Kapur, S., Geller, D., Fung, J. J., & Pinna, A. (1999). Excision and immediate revascularization for hepatic artery pseudoaneurysm following liver transplantation. TRANSPLANTATION PROCEEDINGS, 31(1-2), 443-443.
  
• Strategies to expand the donor pool for pancreas transplantation Kapur, S., Bonham, C. A., Dodson, S. F., Dvorchik, I., & Corry, R. J. (1999). Strategies to expand the donor pool for pancreas transplantation. TRANSPLANTATION, 67(2), 284-290.
  
• Central nervous system lesions in liver transplant recipients - Prospective assessment of indications for biopsy and implications for management Bonham, C. A., Dominguez, E. A., Fukui, M. B., Paterson, D. L., Pankey, G. A., & Singh, N. (1998). Central nervous system lesions in liver transplant recipients - Prospective assessment of indications for biopsy and implications for management. TRANSPLANTATION, 66(12), 1596-1604.
  
• Immunosuppressive agents: Recent developments in molecular action and clinical application Gerber, D. A., Bonham, C. A., & Thomson, A. W. (1998). Immunosuppressive agents: Recent developments in molecular action and clinical application. TRANSPLANTATION PROCEEDINGS, 30(4), 1573-1579.
  
• Surgical complications in 123 consecutive pancreas transplant recipients: Comparison of bladder and enteric drainage Sugitani, A., Gritsch, H. A., Shapiro, R., Bonham, C. A., Egidi, M. F., & Corry, R. J. (1998). Surgical complications in 123 consecutive pancreas transplant recipients: Comparison of bladder and enteric drainage. TRANSPLANTATION PROCEEDINGS, 30(2), 293-294.
  
• Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus Iyengar, A. R., Bonham, C. A., Antonysamy, M. A., Subbotin, V. M., Khanna, A., & Thomson, A. W. (1997). Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus. TRANSPLANTATION, 63(9), 1193-1199.
  
• Nitric oxide production by dendritic cells is associated with impairment of T cell responses Bonham, C. A., Lu, L., Hoffman, R. A., SIMMONS, R. L., & Thomson, A. W. (1997). Nitric oxide production by dendritic cells is associated with impairment of T cell responses. TRANSPLANTATION PROCEEDINGS, 29(1-2), 1116-1117.
  
• Generation of nitric oxide by mouse dendritic cells and its implications for immune response regulation Bonham, C. A., Lu, L., Hoffman, R. A., SIMMONS, R. L., & Thomson, A. W. (1997). Generation of nitric oxide by mouse dendritic cells and its implications for immune response regulation. DENDRITIC CELLS IN FUNDAMENTAL AND CLINICAL IMMUNOLOGY, VOL 3, 417, 283-290.
  
• Nitric oxide production by mouse bone marrow-derived dendritic cells - Implications for the regulation of allogeneic T cell responses Bonham, C. A., Lu, L., Li, Y. P., Hoffman, R. A., SIMMONS, R. L., & Thomson, A. W. (1996). Nitric oxide production by mouse bone marrow-derived dendritic cells - Implications for the regulation of allogeneic T cell responses. TRANSPLANTATION, 62(12), 1871-1877.
  
• Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells - Nitric oxide production is associated with dendritic cell apoptosis Lu, L. N., Bonham, C. A., Chambers, F. G., Watkins, S. C., Hoffman, R. A., & Thomson, A. W. (1996). Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells - Nitric oxide production is associated with dendritic cell apoptosis. JOURNAL OF IMMUNOLOGY, 157(8), 3577-3586.
  
• TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. Bonham, C. A., Lu, L., Banas, R. A., Fontes, P., Rao, A. S., & Thomson, A. W. (1996). TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. Transplant immunology, 4(3), 186-191.
  
• MODE OF ACTION OF TACROLIMUS (FK506) - MOLECULAR AND CELLULAR MECHANISMS Thomson, A. W., Bonham, C. A., & Zeevi, A. (1995). MODE OF ACTION OF TACROLIMUS (FK506) - MOLECULAR AND CELLULAR MECHANISMS. THERAPEUTIC DRUG MONITORING, 17(6), 584-591.
  
• ANTIINFLAMMATORY AGENTS IN ALLERGIC DISEASES Bonham, C. A., & Thomson, A. W. (1995). ANTIINFLAMMATORY AGENTS IN ALLERGIC DISEASES. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 102(1), 1-5.
  
• Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506) - Its relevance to therapy of HIV infection Thomson, A. W., & Bonham, C. A. (1995). Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506) - Its relevance to therapy of HIV infection. CELL ACTIVATION AND APOPTOSIS IN HIV INFECTION, 374, 211-216.